I agree. The RMS shareholders should be asking their management a lot of hard questions.
In a sense I think they were forced into the rushed TO by the recent Mace announcement. I think they have had their eye on EXU for a while, but when the first results on the scale of Mace were released they felt they had to act before EXU could get out a MRE and scoping study on it. Mace really changes the whole value proposition of EXU because of how shallow and high grade it is - I know CMM wishes it had a Mace-like deposit right now.
EXU Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held